FRANKFURT (dpa-AFX) - The breakout of Fresenius shares failed once again on Tuesday in a weak market environment. Although the shares of the Bad Homburg-based company bucked the Dax trend and were up half a percent at 29.32 euros, they were unable to hold their daily high of 29.69 euros. Shares in the holding FMC were little changed.

In his outlook for the Fresenius Capital Markets Day on Wednesday, HSBC expert Sezgi Oezener recommended buying the shares with a target price of 38 euros. Oezener expects the focus to be on the hospital subsidiary Helios with its different growth prospects in Germany and Spain. However, the biopharma segment remains the key driver for Fresenius. Here, he sees an increasing probability that the targets will be exceeded.

For FMC, Oezener continues to vote "Hold" with a slightly higher price target of 39 euros./ag/jha/